top of page


European Vaccine Initiative (EVI) is organised as an Association (e.V) under German law, and with a recognised status as a non-profit organisation. The founding institutions of EVI were Stockholm and Heidelberg Universities, and the current members of the Association are the Biomedical Primate Research Centre, Rijswijk, NL; Heidelberg University, Heidelberg, DE; the Jenner Vaccine Foundation, Oxford, UK; Pasteur Institut, Paris, FR and the Royal College of Surgeons in Ireland, Dublin, IE.

General Assembly

EVI is governed by a general assembly, which is the highest decision-making body of EVI. The General Assembly approves EVI policies and appoints the Executive Director, the Finance and Risk Management Committee (FRMC) and the Strategic Scientific Advisory Committee (SSAC).

Strategic Scientific Advisory Committee


The Strategic Scientific Advisory Committee (SSAC) is composed of stakeholders from vaccine development, low income populations and other parties with vested interest such as, international experts in vaccine R&D, vaccinology, epidemiology, immunology, infectious diseases, ethics, microbiology and pharmaceutical development. The committee operates independently, and has the mission to advise EVI on all matters of scientific-technical nature, on research, development and access to vaccines as well as supporting fundraising efforts and outreach activities.

EVI Staff


EVI has an international team of committed staff and close collaborators. Our diverse team represents multiple nationalities and brings together experienced professionals with backgrounds in academia, non-profit organisations, the private sector and public institutions. EVI staff members implement the decisions of the General Assembly, liaise and negotiate with partners, oversee funded programmes and maintain financial and operational control systems.

Our headquarters are in Heidelberg, Germany.

bottom of page